Keybank National Association OH lessened its stake in shares of Aetna Inc (NYSE:AET) by 0.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 426,226 shares of the company’s stock after selling 804 shares during the quarter. Keybank National Association OH’s holdings in Aetna were worth $76,887,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in AET. Wells Fargo & Company MN boosted its position in shares of Aetna by 4.2% in the 3rd quarter. Wells Fargo & Company MN now owns 1,365,596 shares of the company’s stock worth $217,144,000 after purchasing an additional 54,928 shares in the last quarter. Fayez Sarofim & Co. boosted its position in shares of Aetna by 82.8% in the 3rd quarter. Fayez Sarofim & Co. now owns 7,427 shares of the company’s stock worth $1,181,000 after purchasing an additional 3,365 shares in the last quarter. California Public Employees Retirement System boosted its position in shares of Aetna by 9.4% in the 3rd quarter. California Public Employees Retirement System now owns 910,189 shares of the company’s stock worth $144,729,000 after purchasing an additional 78,363 shares in the last quarter. Prudential Financial Inc. boosted its position in shares of Aetna by 3.6% in the 3rd quarter. Prudential Financial Inc. now owns 1,089,269 shares of the company’s stock worth $173,205,000 after purchasing an additional 38,223 shares in the last quarter. Finally, Commonwealth Bank of Australia boosted its position in shares of Aetna by 2.9% in the 3rd quarter. Commonwealth Bank of Australia now owns 45,887 shares of the company’s stock worth $7,290,000 after purchasing an additional 1,291 shares in the last quarter. 87.10% of the stock is currently owned by institutional investors and hedge funds.

Shares of Aetna Inc (AET) opened at $178.52 on Wednesday. Aetna Inc has a 52-week low of $121.60 and a 52-week high of $194.40. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 1.68. The company has a market capitalization of $57,993.06, a PE ratio of 18.05, a price-to-earnings-growth ratio of 1.44 and a beta of 0.60.

Aetna (NYSE:AET) last released its quarterly earnings data on Tuesday, January 30th. The company reported $1.25 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.18 by $0.07. The business had revenue of $14.74 billion during the quarter, compared to analyst estimates of $14.79 billion. Aetna had a return on equity of 21.50% and a net margin of 3.15%. The company’s revenue was down 6.2% on a year-over-year basis. During the same quarter last year, the business posted $0.08 EPS. equities analysts forecast that Aetna Inc will post 10.99 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Shareholders of record on Thursday, January 11th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.12%. Aetna’s payout ratio is currently 34.78%.

AET has been the subject of a number of recent analyst reports. Cantor Fitzgerald reissued a “neutral” rating and issued a $175.00 price objective on shares of Aetna in a research report on Monday, October 23rd. Zacks Investment Research cut Aetna from a “buy” rating to a “hold” rating in a research report on Tuesday, October 24th. BMO Capital Markets raised their price objective on Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a research report on Friday, October 27th. Jefferies Group raised their price objective on Aetna from $165.00 to $185.00 and gave the stock a “hold” rating in a research report on Wednesday, November 1st. Finally, Citigroup raised their price objective on Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a research report on Thursday, November 2nd. Ten investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $185.94.

ILLEGAL ACTIVITY WARNING: This report was first reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another domain, it was copied illegally and reposted in violation of U.S. & international copyright law. The correct version of this report can be accessed at https://www.dailypolitical.com/2018/02/14/keybank-national-association-oh-sells-804-shares-of-aetna-inc-aet.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.